论文部分内容阅读
作者用 Quik-Sep 简易测定装置测定了15名健康人(29.7±9.8岁)和55例原发性糖尿病患者的 HbA_1,糖尿病患者中单纯饮食疗法组17例,54.3±17.3岁,口服药治疗组27例,55.6±11.1岁,胰岛素治疗组11例,60.6±13岁。测定 HbA_1的最佳温度为22.5℃,尽量在当日或次日测定,结果健康人 HbA_1为6.29±0.59％(M±1SD)。糖尿病患者中,饮食疗法组为6.7±0.91％,口服药治疗组为8.23±1.63％,胰岛素治疗纽为9.14±1.4％,药物治疗组较单纯饮食疗法组明显增高,而口服药治疗组与胰岛素治疗组无明
The authors measured the HbA_1 in 15 healthy individuals (29.7 ± 9.8 years) and in 55 patients with primary diabetes using the Quik-Sep simple assay device, 17 patients in the diet-alone diabetic group, 54.3 ± 17.3 years of age, and 27 Cases, 55.6 ± 11.1 years old, 11 cases of insulin treatment group, 60.6 ± 13 years old. The best temperature for determination of HbA_1 was 22.5 ℃. The best HbA_1 was 6.29 ± 0.59% (M ± 1SD) on the same day or next day. Diabetic patients, the diet therapy group was 6.7 ± 0.91%, the oral medication group was 8.23 ± 1.63%, insulin treatment New Zealand was 9.14 ± 1.4%, drug treatment group was significantly higher than the diet group, while the oral drug treatment group and insulin treatment group Unknown